2-cyanomethyl-benzenesulfonyl chloride | 27350-00-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-cyanomethyl-benzenesulfonyl chloride
• 英文别名: o-Cyanomethylbenzosulfonylchlorid；o-Cyanmethyl-benzolsulfochlorid；o-Cyanmethylbenzolsulfochlorid；2-(Cyanomethyl)benzene-1-sulfonyl chloride；2-(cyanomethyl)benzenesulfonyl chloride
• CAS: 27350-00-1
• 化学式: C₈H₆ClNO₂S
• mdl: MFCD19200115
• 分子量: 215.66
• InChiKey: CFBPIKYUENXQHC-UHFFFAOYSA-N

物化性质

• 熔点：
  109-111 °C
• 沸点：
  371.1±25.0 °C(Predicted)
• 密度：
  1.416±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  66.3
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-cyanomethyl-benzenesulfonyl chloride 在 4-二甲氨基吡啶 、 ammonium hydroxide 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 5.0h， 生成 N-(2-(cyanomethyl)phenylsulfonyl)-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide
  参考文献：
  名称：

  Design and synthesis of triazolopyrimidine acylsulfonamides as novel anti-mycobacterial leads acting through inhibition of acetohydroxyacid synthase

  摘要：

  Novel triazolopyrimidine acylsulfonamides class of antimycobacterial agents, which are mycobacterial acetohydroxyacid synthase (AHAS) inhibitors were designed by hybridization of known AHAS inhibitors such as sulfonyl urea and triazolopyrimidine sulfonamides. This Letter describes the synthesis and SAR studies of this class of molecules by variation of two parts of the molecule, the phenyl and triazolopyrimidine rings. SAR study describes optimisation of enzyme potency, whole cell potency and evidence of mechanism of action. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2014.02.054

文献信息

• Studies on the synthesis of condensed heterocyclic isoquinolone derivatives. I. Studies on the synthesis and pharmacology of thiazino, oxazino and pyrimido isoquinolones.
  作者：KAZUO KUBO、NORIKI ITO、YASUO ISOMURA、ISAO SOZU、HIROSHIGE HOMMA、MASUO MURAKAMI

  DOI：10.1248/cpb.27.2372

  日期：——

  5-Oxo-1, 2, 3, 5-tetrahydro-5H-imidazo [1, 2-b] isoquinoline (IIa) and related compounds were synthesized from homophthalic acid and an aliphatic 1, 2- or 1, 3-diamine. In addition, homophthalic acids or o-carboxyphenylmalonic acid diesters were allowed to react with an aliphatic 1, 2- or 1, 3-aminoalcohol or aminothiol with heating in the presence of p-toluenesulfonic acid, yielding a series of oxazolo- or oxazino-isoquinolones (VI) or thiazolo- or thiazino-isoquinolones (IV). Oxidation of IV gave the corresponding sulfoxides (VII) and sulfones (VIII). Treatment of o-cyanomethylbenzenesulfonyl chloride with an N-alkyl 1, 2- or 1, 3-diamine gave N-alkyl-imidazo- or pyrimido-benzothiazine-5, 5-dioxide (XI). The compounds thus prepared were evaluated for their anti-inflammatory effect in rats, using the carrageenin paw edema method, and some of the condensed heterocyclic isoquinolone derivatives were found to exhibit strong anti-inflammatory activity. These compounds were also examined for analgesic activity in terms of the inhibition of acetic acid induced writhing. Compound VIIIk showed stronger anti-inflammatory activity than phenylbutazone, as well as analgesic activity comparable to that of aminopyrine, and had very low toxicity.

  5-氧代-1，2，3，5-四氢-5H-咪唑并[1，2-b]异喹啉（IIa）及相关化合物由均苯二甲酸和脂肪族 1，2-或 1，3-二胺合成。此外，均苯二甲酸或邻羧基苯丙二酸二酯与脂肪族 1、2- 或 1、3-氨基醇或氨基硫醇在对甲苯磺酸存在下加热反应，可生成一系列噁唑或噁唑-异喹啉酮（VI）或噻唑或噻嗪-异喹啉酮（IV）。IV 氧化后得到相应的硫醚（VII）和砜（VIII）。用 N-烷基 1，2-或 1，3-二胺处理邻氰甲基苯磺酰氯，可得到 N-烷基咪唑或嘧啶基苯并噻嗪-5，5-二氧化物（XI）。采用角叉菜胶爪水肿法对由此制备的化合物进行了大鼠抗炎效果评估，发现其中一些缩合杂环异喹啉酮衍生物具有很强的抗炎活性。这些化合物还通过抑制醋酸引起的蠕动来检测其镇痛活性。化合物 VIIIk 显示出比苯基丁氮酮更强的抗炎活性，以及与氨基比林相当的镇痛活性，而且毒性很低。
• Hydroxamic and carboxylic acid derivatives
  申请人：——

  公开号：US20030022893A1

  公开（公告）日：2003-01-30

  The subject invention concerns methods and compounds that have utility in the treatment of a condition associated with matrix metalloproteinase, ADAM or ADAM-TS enzymes, a condition that is mediated by TNF &agr; or a condition involving a membrane-shedding event that is mediated by a metalloproteinase. Compounds of the invention are of formula I (B) 2 N—X—(CH 2 ) m -W-(CR 1 R 2 ) n —COY  (I) wherein n=0 or 1; m=0 or 1; X is S(O) 1-2 ; Y is OH or NHOH; W is aryl or heteroaryl; and the other groups are as defined herein.

  本发明涉及用于治疗与基质金属蛋白酶、ADAM或ADAM-TS酶相关的疾病、由TNFα介导的疾病或由金属蛋白酶介导的膜剥离事件相关的疾病的方法和化合物。本发明的化合物的化学式为I（B）2N—X—（CH2）m-W-（CR1R2）n—COY（I），其中n=0或1；m=0或1；X为S（O）1-2；Y为OH或NHOH；W为芳基或杂环芳基；其他基团如本文所定义。
• KUBO K.; ITO N.; ISOMURA Y.; SOZU I.; HOMMA H.; MURAKAMI M., CHEM. AND PHARM. BULL., 1979, 27, NO 10, 2372-2381
  作者：KUBO K.、 ITO N.、 ISOMURA Y.、 SOZU I.、 HOMMA H.、 MURAKAMI M.

  DOI：——

  日期：——
• HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES
  申请人：Darwin Discovery Limited

  公开号：EP1163213A1

  公开（公告）日：2001-12-19
• US6465468B1
  申请人：——

  公开号：US6465468B1

  公开（公告）日：2002-10-15